Bio Plus Co., Ltd (KOSDAQ:099430)
South Korea · Delayed Price · Currency is KRW 5,880.00
+760.00 (14.84%)
May 21, 2026, 3:30 PM KST
Bio Plus Market Cap
Bio Plus has a market cap or net worth of 361.86 billion as of May 20, 2026. Its market cap has decreased by -21.01% in one year.
Market Cap
361.86B
Enterprise Value
414.87B
Revenue
90.90B
Ranking
n/a
PE Ratio
39.46
Stock Price
5,880.00
Market Cap Chart
Since September 27, 2021, Bio Plus's market cap has decreased from 451.40B to 361.86B, a decrease of -19.84%. That is a compound annual growth rate of -4.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 20, 2026 | 315.09B | 1.79% |
| Dec 30, 2025 | 309.55B | -24.79% |
| Dec 30, 2024 | 411.57B | 4.76% |
| Dec 28, 2023 | 392.88B | -2.28% |
| Dec 29, 2022 | 402.04B | 1.78% |
| Dec 30, 2021 | 395.00B | -12.50% |
| Sep 27, 2021 | 451.40B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ToolGen | 719.31B |
| WON TECH | 651.25B |
| InBody Co.,Ltd | 590.88B |
| Curexo | 538.85B |
| i-SENS | 511.86B |
| DRTECH | 134.82B |
| Ray Co., Ltd. | 116.55B |
| T&R Biofab | 114.40B |